iifl-logo

Dr Lal Pathlabs Ltd Annually Results

2,777.8
(-1.21%)
Apr 29, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

2,461.4

2,226.6

2,016.9

2,087.4

1,581.3

Excise Duty

0

0

0

0

0

Net Sales

2,461.4

2,226.6

2,016.9

2,087.4

1,581.3

Other Operating Income

0

0

0

0

0

Other Income

93.4

69.2

41.7

52.5

51.3

Total Income

2,554.8

2,295.8

2,058.6

2,139.9

1,632.6

Total Expenditure

1,765.9

1,617.3

1,527

1,526.7

1,145

PBIDT

788.9

678.5

531.6

613.2

487.6

Interest

22.3

29.4

37.5

30.2

16

PBDT

766.6

649.1

494.1

583

471.6

Depreciation

141.9

143.6

150.2

108.1

77.2

Minority Interest Before NP

0

0

0

0

0

Tax

172

148

107.9

126.5

102.1

Deferred Tax

-39.5

-4.8

-5.1

-1.9

-4.2

Reported Profit After Tax

492.2

362.3

241.1

350.3

296.5

Minority Interest After NP

5.1

4.6

2.2

5.5

4.9

Net Profit after Minority Interest

487.1

357.7

238.9

344.8

291.6

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

487.1

357.7

238.9

344.8

291.6

EPS (Unit Curr.)

58.48

43.05

28.82

41.7

35.33

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

240

180

60

120

200

Equity

83.6

83.5

83.4

83.3

83.3

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

32.05

30.47

26.35

29.37

30.83

PBDTM(%)

31.14

29.15

24.49

27.92

29.82

PATM(%)

19.99

16.27

11.95

16.78

18.75

Dr Lal Pathlabs: Related NEWS

Dr Lal PathLabs Reports 81.4% Profit Jump in Q4 Result
28 Apr 2025|12:38 PM

Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.

Read More
Dr. Lal PathLabs Q3 Profit Up 19% YoY, Announces ₹6 Dividend
31 Jan 2025|05:04 PM

The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.